(Q53500269)
Statements
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide. (English)
Rodney J Ellis
Hang Zhou
Edward Y Kim
Pingfu Fu
Deborah A Kaminsky
Bruce Sodee
Valdir Colussi
Waseet Z Vance
John P Spirnak
Carolyn Kim
Martin I Resnick
1 January 2007
6
1
16-25